SOPH insider reports multiple 10b5-1 sales

Jurgi Camblong reported multiple sales of Common Stock under a 10b5-1 plan.

Rhea-AI Filing Summary

Jurgi Camblong reported multiple sales of Common Stock under a 10b5-1 plan. The filing lists a series of open-market dispositions dated April through June 2026, showing individual sale sizes and proceeds for each trade. The record also notes an exercise of stock options for 50,000 shares on 06/26/2026.

Key Figures

Largest single listed sale: 43,129 shares Notable sale: 17,473 shares Recent sale: 1,373 shares +2 more

5 metrics

Largest single listed sale 43,129 shares 04/14/2026 sale showing proceeds $213,833.58

Notable sale 17,473 shares 04/15/2026 sale showing proceeds $87,401.69

Recent sale 1,373 shares 06/25/2026 sale showing proceeds $7,826.10

Option exercise 50,000 shares Exercise of Stock Options on 06/26/2026, payment method: Cash

Other listed trades (example) 8,500 shares 06/10/2026 sale showing proceeds $44,500.90

Key Terms

10b5-1, Exercise of Stock Options, Founders Shares

3 terms

10b5-1 regulatory

"10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle"

A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.

Exercise of Stock Options financial

"06/26/2026 | Exercise of Stock Options | Issuer | 50,000"

Founders Shares market

"Common | 03/18/2021 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the SOPH Form 144 disclose about insider activity?

It discloses multiple 10b5-1 sales by Jurgi Camblong totaling many individual transactions. The filing lists dates, share counts, and gross proceeds for each sale from 04/06/2026 through 06/25/2026, plus a separate option exercise of 50,000 shares on 06/26/2026.

How many shares were sold in the largest single trade listed on the Form 144?

The largest single trade shown is 43,129 shares on 04/14/2026. The filing pairs each trade with gross proceeds; that sale lists proceeds of $213,833.58 alongside the share count.

Were the sales made under a trading plan or as discretionary trades?

The sales are reported as 10b5-1 sales, indicating they were executed under a pre-established trading plan. Each sale line in the filing is labeled "10b5-1 Sales," which is the verbatim descriptor used in the excerpt.

Does the Form 144 show any option exercises by the reporting person?

Yes. The excerpt shows an exercise of stock options for 50,000 shares on 06/26/2026 with payment method listed as Cash. That exercise is shown separately from the 10b5-1 sale entries.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/26/2026 - 04:31 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002007050
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	JURGI CAMBLONG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	68129	387654.01	71790366	06/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/18/2021	Founders Shares	Issuer			18129	03/18/2021	N/A
Common	06/26/2026	Exercise of Stock Options	Issuer			50000	06/26/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/25/2026	1373	7826.10
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/10/2026	8500	44500.90
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	05/19/2026	4486	20657.58
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	05/11/2026	8500	43241.20
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/20/2026	4486	23349.63
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/15/2026	17473	87401.69
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/14/2026	43129	213833.58
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/13/2026	4399	20957.28
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/10/2026	12232	57710.79
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/09/2026	1950	9243.78
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/08/2026	2800	13553.12
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/07/2026	2500	12154.75
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	04/06/2026	2600	12614.42

144: Remarks and Signature

Remarks	The 50,000 securities to be sold were and will be received upon the exercise of stock options over the next three months. The dates of acquisition and payment were and will be the dates of exercise/sale.
Date of Notice	06/26/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jurgi Camblong
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)